Zynrelef Europska Unija - hrvatski - EMA (European Medicines Agency)

zynrelef

heron therapeutics, b.v. - bupivacaine, meloxicam - bol, postoperativna - anestetici - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.

Exparel liposomal Europska Unija - hrvatski - EMA (European Medicines Agency)

exparel liposomal

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Nitisinone MDK (previously Nitisinone MendeliKABS) Europska Unija - hrvatski - EMA (European Medicines Agency)

nitisinone mdk (previously nitisinone mendelikabs)

mendelikabs europe ltd - nitisinone - tyrosinemias - drugi gastrointestinalni trakt i metabolizam, lijekovi, - liječenje odraslih i pedijatrijskih (u bilo kojoj dobnoj skupini) bolesnika s potvrđenom dijagnozom nasljedne tirozinemije tip 1 (ht1) u kombinaciji s prehrambenim ograničenjem tirozina i fenilalanina.

Orfadin Europska Unija - hrvatski - EMA (European Medicines Agency)

orfadin

swedish orphan biovitrum international ab - nitisinone - tyrosinemias - drugi gastrointestinalni trakt i metabolizam, lijekovi, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

Nityr Europska Unija - hrvatski - EMA (European Medicines Agency)

nityr

cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - drugi gastrointestinalni trakt i metabolizam, lijekovi, - liječenje i pedijatrijski bolesne odrasle osobe s potvrđene dijagnoze nasljedne тирозинемии 1 (ХТ-1) u kombinaciji s prehrambenim ograničenjima tirozin i fenilalanin.